Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Drug Study (With Single and Parallel Group Components) to Evaluate Combination Antimalarial Therapy for Efficacy, Gametocyte Carriage and Molecular Markers Associated With SP Resistance in Uncomplicated Plasmodium Falciparum Infections

NCT00203736 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT00203736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Drug Study (With Single and Parallel Group Components) to Evaluate Combination Antimalarial Therapy for Efficacy, Gametocyte Carriage and Molecular Markers Associated With SP Resistance in Uncomplicated Plasmodium Falciparum Infections
Lead sponsor
University of Cape Town
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2003
Completion date
October 31, 2003
Enrollment
240
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria